GENE ONLINE|News &
Opinion
Blog

.

Зеркало официального сайта всегда доступно для входа на Мостбет, даже при ограничениях. Скачать Mostbet – это шаг к удобству и азартным развлечениям.

Если вы ищете место для увлекательных ставок, обратите внимание на Joycasino, где лучшие предложения для игроков ждут вас.
2021-09-09| Licensing

Eli Lilly Forays Into RNA Editing, Betting More than a Billion Dollars on ProQR’s Technology

by Rajaneesh K. Gopinath
Share To
Just months after teaming up with London-based MiNA Therapeutics to capitalize on the latter's small activating RNA technology platform, Pharma giant Eli Lilly has inked another RNA deal worth over a billion dollars.

On September 8th, news broke that Dutch biotech ProQR Therapeutics has signed a global licensing and research collaboration with Eli Lilly to develop editing oligonucleotides or EONs using ProQR’s proprietary RNA editing platform, Axiomer. The collaboration intends to advance up to five drug targets toward clinical development and commercialization.

As per the terms, ProQR will receive $50 million from Eli Lilly, comprising an upfront payment of $20 million and $30 million in equity investment. ProQR is also eligible to receive up to $1.25 billion in biobucks if certain development, regulatory, and commercialization milestones are met. In addition, it also stands to gain tiered royalties on product sales.

GO Prime with only $1.49 now

LATEST
South Korea’s Olix Strikes $660M Deal with Eli Lilly for Phase 1 MASH candidate
2025-02-11
22 USA States Sue Trump Administration for Slashing Critical Medical Research Funding
2025-02-11
The Fallout of the USAID Funding Freeze: Implications for Global Health and Biopharmaceutical Innovation
2025-02-11
Trump’s Trade War Shake-Up: How U.S. Tariffs Could Disrupt Global Pharma
2025-02-10
Precision Medicine Market Skyrocketing, Shaking the Industry with $470.53 Billion Expected by 2034
2025-02-10
Super Bowl LIX and the Biotech Sector: A New Arena for Engagement
2025-02-09
What the PlayStation Network Outage Can Teach the Biotech Industry
2025-02-08
EVENT
2025-02-19
Healthcare Conference Taipei 2025
Taipei, Taiwan
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
Scroll to Top